Effects of Monitoring Blood Pressure During Pregnancy

Launched by XINHUA HOSPITAL, SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE · Jan 11, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effects of monitoring blood pressure during pregnancy, specifically for women at higher risk of developing high blood pressure. At least 400 pregnant women will take part in the study, wearing a device that tracks their blood pressure from 12 to 28 weeks of pregnancy. The goal is to see how this monitoring impacts both the mothers and their babies, particularly in terms of birth weight and weight gain. Participants will be from three hospitals in China and will be divided into two groups: one will receive regular check-ups, while the other will use the wearable device along with their usual care.

To be eligible for this study, women must be pregnant with one baby and be less than 12 weeks along. They should also have certain risk factors, such as being over 30 years old, having a history of high blood pressure or diabetes, or having a family history of pregnancy-related complications. Participants will be expected to attend regular check-ups and will need to provide informed consent to join the study. This trial is not yet recruiting participants, but it aims to better understand how monitoring blood pressure can help improve health outcomes for both mothers and their babies during pregnancy.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Women with a single pregnancy before 12 weeks of pregnancy
• • The presence of any of the following risk factors: age \> 30 years, a history of eclampsia, a family history of eclampsia, obesity (BMI ≥ 30 Kg/m2), and a history of gestational hyperglycemia (pregestational type 1 and type 2 diabetes; gestational manifest diabetes and gestational diabetes requiring insulin treatment), preexisting chronic hypertension, kidney disease, and autoimmune diseases such as systemic lupus erythematosus and antiphospholipid syndrome.
• • Signed the informed consent can be continuously followed up.
• • Permanent population living in the study area.
• • All subjects received routine antenatal examination and treatment.
• Exclusion Criteria:
• • Termination of pregnancy before 20 weeks
• • Withdraw from the study
• • Lost visitors